[1] DEVARBHAVI H. An update on drug-induced liver injury[J].J Clin Exp Hepatol,2012,2(3):247-259.
|
[2] Drug-induced Liver Disease Study Group,Chinese Society of Hepatology,Chinese Medical Association. Guidelines for the management of drug-induced liver injury[J]. J Clin Hepatol,2015,31(11):1752-1769.(in Chinese)中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志,2015,31(11):1752-1769.
|
[3] Branch of Hepatobiliary Diseases,China Association of Chinese Medicine; Branch of Chinese Patent Medicine,China Association of Chinese Medicine. Guideline for diagnosis and treatment of herb-induced liver injury[J]. J Clin Hepatol,2016,32(5):835-843.(in Chinese)中华中医药学会肝胆病分会,中华中医药学会中成药分会.中草药相关肝损伤临床诊疗指南[J].临床肝胆病杂志,2016,32(5):835-843.
|
[4] TENG GJ,LIANG QS,SUN Y,et al. Clinical features and pathological analysis of 186 patients with liver injury induced by Chinese herbal medicine[J]. Chin Arch Tradit Chin Med,2014,32(4):913-916.(in Chinese)滕光菊,梁庆升,孙颖,等.165例中草药导致药物性肝损害临床特征及病理分析[J].中华中医药学刊,2014,32(4):913-916.
|
[5] DANAN G,BENICHOU C. Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings:Application to drug-induced liver injuries[J]. J Clin Epidemiol,1993,46(11):1323-1330.
|
[6] Drug-induced Liver Disease Study Group,Chinese Society of Hepatology,Chinese Medical Association. Interpretation of guidelines for the management of drug-induced liver injury[M].Shanghai:Science and Technology Press,2015:34-35.(in Chinese)中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南解读[M].上海:科学技术出版社,2015:34-35.
|
[7] KLEINER DE. The histopathological evaluation of drug-induced liver injury[J]. Histopathology,2017,70(1):81-93.
|
[8] ZHU CW,WANG HN,YUAN JL,et al. Clinical features of drug-induced liver injury:An analysis of 445 cases[J]. J Clin Hepatol,2018,34(2):354-358.(in Chinese)朱春雾,王海南,袁继丽,等.445例药物性肝损伤的临床分析[J].临床肝胆病杂志,2018,34(2):354-358.
|
[9] GUO LJ,ZHANG HC,YE LH,et al. Clinical and pathological features of drug-induced liver injury caused by TCM and Western medicine[J]. Clin Misdiagn Misther,2019,32(8):28-33.(in Chinese)郭立杰,张海丛,叶立红,等.中西药所致药物性肝损伤临床及病理特点分析[J].临床误诊误治,2019,32(8):28-33.
|
[10] WANG JL,ZHOU CF. Research progress of Chinese herbal medicine and traditional Chinese medicine resulting in liver injury[J]. China J Chin Mater Med,2011,36(23):3371-3374.(in Chinese)王京丽,周超凡.中草药及其制剂对肝损伤的研究概述[J].中国中药杂志,2011,36(23):3371-3374.
|
[11] WANG T,ZHAO X,SHAO C,et al. A proposed pathologic sub-classification of drug-induced liver injury[J]. Hepatol Int,2019,13(3):339-351.
|
[12] Cooperative Group for Hepatic and Gall Diseases,Chinese Society of Gastroenterology, Chinese Medical Association.Expert consensus on diagnosis and treatment of pyrrolidine alkaloids-related sinusoidal obstruction syndrome(2017,Nanjing)[J]. J Clin Hepatol,2017,33(9):1627-1637.(in Chinese)中华医学会消化病学分会肝胆疾病协作组.吡咯生物碱相关肝窦阻塞综合征诊断和治疗专家共识意见(2017年,南京)[J].临床肝胆病杂志,2017,33(9):1627-1637.
|
[13] WANG HM. Analysis of biochemical parameters and pathological characteristics of acute drug-induced liver injury induced by traditional Chinese medicine[J]. China Pharm,2015,24(24):58-60.(in Chinese)王洪梅.中药致急性药物性肝损伤的生化指标及病理特点分析[J].中国药业,2015,24(24):58-60.
|
[14] LIU FF,DUAN XZ,ZANG H,et al. Comparative analysis of clinical and hepatic pathologic features in patients with acute drug-induced liver injury caused by traditional Chinese herbs and western medicines[J]. J Prac Hepatol,2013,16(4):317-319.(in Chinese)柳芳芳,段学章,臧红,等.中药和西药致急性药物性肝损伤临床和肝组织病理学特征对比分析[J].实用肝脏病杂志,2013,16(4):317-319.
|
[15] HE TT,GONG M,WANG LF,et al. Prospective study on pathological features and traditional Chinese medicine syndrome types of patients with herb-induced liver injury[J].Chin J Integr Trad West Med,2019,39(8):932-936.(in Chinese)何婷婷,宫嫚,王立福,等.中药肝损伤病例的病理特征及中医证型前瞻性研究[J].中国中西医结合杂志,2019,39(8):932-936.
|